-
Feb 12, 2021 10:16 AM IST Research house Macquarie has kept outperform rating with a target at Rs 700.
-
Feb 09, 2021 10:53 PM IST Sharekhan is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 700 in its research report dated January 29, 2021.
-
Feb 07, 2021 01:11 PM IST The US arm of the domestic pharma major is recalling Testosterone Cypionate Injection in the American market, according to the latest enforcement report of the US Food and Drug Administration.
-
Feb 05, 2021 08:56 PM IST Prabhudas Lilladher is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 672 in its research report dated February 01, 2021.
-
Feb 05, 2021 07:11 PM IST ICICI Direct is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 675 in its research report dated January 31, 2021.
-
Feb 04, 2021 06:44 PM IST Prabhudas Lilladher recommended hold rating on Sun Pharmaceutical Industries with a target price of Rs 602 in its research report dated January 28, 2021.
-
Feb 02, 2021 09:55 AM IST -
Feb 02, 2021 09:11 AM IST -
Dec 15, 2020 02:27 PM IST Sharekhan is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 660 in its research report dated December 14, 2020.
-
Nov 07, 2020 01:40 PM IST ICICI Direct is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 585 in its research report dated November 04, 2020.
-
Nov 06, 2020 04:44 PM IST Prabhudas Lilladher is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 597 in its research report dated November 04, 2020.
-
Nov 05, 2020 05:07 PM IST Sharekhan is bullish on Sun Pharmaceutical Industries recommended buy rating on the stock with a target price of Rs 612 in its research report dated November 03, 2020.
-
Nov 04, 2020 11:22 AM IST -
Nov 03, 2020 04:35 PM IST Prabhudas Lilladher recommended Reduce rating on Sun Pharmaceutical Industries with a target price of Rs 476 in its research report dated October 30, 2020.
-
Nov 03, 2020 03:29 PM IST Consolidated revenue from operations grew by 5.3 percent year-on-year to Rs 8,553 crore in September quarter.
-
Nov 03, 2020 07:37 AM IST Sun Pharma's key facility Halol continues to be under FDA issue which has slowed down new approvals.
-
Sep 23, 2020 09:36 AM IST The company's wholly-owned Japanese subsidiary has launched ILUMYA Subcutaneous Injection 100 mg Syringe in Japan.
-
Aug 10, 2020 12:59 PM IST ICICI Direct is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 625 in its research report dated August 02, 2020.
-
Aug 08, 2020 12:32 PM IST Prabhudas Lilladher recommended reduce rating on Sun Pharmaceutical Industries with a target price of Rs 479 in its research report dated August 02, 2020.
-
Aug 03, 2020 01:59 PM IST Prabhudas Lilladher recommended Hold rating on Sun Pharmaceutical Industries with a target price of Rs 479 in its research report dated July 31, 2020.
-
Aug 03, 2020 09:25 AM IST -
Aug 03, 2020 09:22 AM IST -
Jul 31, 2020 03:36 PM IST Net profit before one-time loss stood at Rs 1,449.4 crore, which grew by 4.5 percent on year-on-year basis.
-
Jul 31, 2020 03:01 PM IST The company had reported a net profit of Rs 1,387.5 crore in the corresponding quarter a year ago.
-
Jul 21, 2020 10:09 PM IST Life Insurance Corporation raised its stake in Godrej Industries to 3.87 percent in June quarter from 3.7 percent in the March quarter